Skip to main content

Arnau Peñalver Piñol

Institutions of which they are part

Predoctoral researcher
Epidemiology and Public Health
Vall Hebron Institut de Recerca

Arnau Peñalver Piñol

Institutions of which they are part

Predoctoral researcher
Epidemiology and Public Health
Vall Hebron Institut de Recerca

Projects

Development of Robust and Innovative Vaccine Effectiveness (DRIVE)

IP: Susana Otero Romero
Collaborators: Eva del Amo Moran, Cristina Andrés Vergés, Arnau Peñalver Piñol
Funding agency: The Innovative Medicines Initiative
Funding: 59690
Reference: DRIVE_IMI2-2018_SUBART11
Duration: 07/08/2018 - 30/09/2019

Related news

The Lancet Neurology publishes the new criteria, the result of a global expert consensus led by Dr Xavier Montalban.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment.

Related professionals

Sílvia Torrents Zapata

Sílvia Torrents Zapata

Research technician
Transfusional Medicine
Read more
Gemma Cuberas Borros

Gemma Cuberas Borros

Research technician
Molecular Imaging and Therapy
Read more
Carles Bravo Masgoret

Carles Bravo Masgoret

Pneumology
Read more
Yoursa El-Kasmy El Kasmi

Yoursa El-Kasmy El Kasmi

Administration and Management
General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.